Latest filing published 20 Feb 2015 for Mimedx Group, INC., €789k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Roberta L. Mccaw across 2 companies, led by Matria Healthcare Inc and Mimedx Group, Inc. Over a trading history stretching from 23 January 2006 to 18 February 2015, the count stands at 30 filings.
The open-market side counts 1 purchase for €113k alongside 5 sales for €1.1M. The net balance comes to €997k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 19 share grants and 4 option exercises. So far in 2015, the count stands at no purchases and 1 sale.
On 20 February 2015 came the latest disclosure, an open-market sale for €789k in Mimedx Group, Inc. The latest purchase dates back some time: it was published 5,189 days ago, on 8 August 2012. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations